Cargando…

Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays

Mostrar otras versiones (1)

The receptor-binding domain (RBD) of the SARS-CoV-2 spike protein is a commonly used antigen for serology assays critical to determining the extent of SARS-CoV-2 exposure in the population. Different versions of the RBD protein have been developed and utilized in assays, with higher sensitivity attr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mehalko, Jennifer, Drew, Matthew, Snead, Kelly, Denson, John-Paul, Wall, Vanessa, Taylor, Troy, Sadtler, Kaitlyn, Messing, Simon, Gillette, William, Esposito, Dominic
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685350/ https://www.ncbi.nlm.nih.gov/pubmed/33236017 http://dx.doi.org/10.1101/2020.11.18.388868

Ejemplares similares

Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays
por: Mehalko, Jennifer, et al.
Publicado: (2021)

Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assays
por: Esposito, Dominic, et al.
Publicado: (2020)

Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assays
por: Esposito, Dominic, et al.
Publicado: (2020)

Standardization of enzyme-linked immunosorbent assays for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling
por: Klumpp-Thomas, Carleen, et al.
Publicado: (2020)

Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal Betacoronaviruses
por: Hicks, Jennifer, et al.
Publicado: (2020)

Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses
por: Hicks, Jennifer, et al.
Publicado: (2021)

Refining the N-Termini of the SARS-CoV-2 Spike Protein and Its Discrete Receptor-Binding Domain
por: D’Ippolito, Robert A., et al.
Publicado: (2021)

Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling
por: Klumpp-Thomas, Carleen, et al.
Publicado: (2021)

Effect of D614G Spike Variant on Immunoglobulin G, M, or A Spike Seroassay Performance
por: Klumpp-Thomas, Carleen, et al.
Publicado: (2020)

Material strategies and considerations for serologic testing of global infectious diseases
por: Manning, Jessica E., et al.
Publicado: (2021)

Serological reactivity of inactivated SARS-CoV-2 vaccine based on an S-RBD neutralizing antibody assay
por: Zhang, Hui, et al.
Publicado: (2022)

Bacillus subtilis spores displaying RBD domain of SARS-CoV-2 spike protein
por: Vetráková, A., et al.
Publicado: (2023)

KRAS interaction with RAF1 RAS-binding domain and cysteine-rich domain provides insights into RAS-mediated RAF activation
por: Tran, Timothy H., et al.
Publicado: (2021)

Homogeneous Dual-Parametric-Coupled Assay for Simultaneous Nucleotide Exchange and KRAS/RAF-RBD Interaction Monitoring
por: Kopra, Kari, et al.
Publicado: (2020)

Serological Test to Determine Exposure to SARS-CoV-2: ELISA Based on the Receptor-Binding Domain of the Spike Protein (S-RBD(N318-V510)) Expressed in Escherichia coli
por: Márquez-Ipiña, Alan Roberto, et al.
Publicado: (2021)

Effect of Delta and Omicron Mutations on the RBD-SD1 Domain of the Spike Protein in SARS-CoV-2 and the Omicron Mutations on RBD-ACE2 Interface Complex
por: Ching, Wai-Yim, et al.
Publicado: (2022)

Identification of Potential Binding Sites of Sialic Acids on the RBD Domain of SARS-CoV-2 Spike Protein
por: Li, Bingqian, et al.
Publicado: (2021)

Utilization of Recombinant Baculovirus Expression System to Produce the RBD Domain of SARS-CoV-2 Spike Protein
por: Fan, Youpeng, et al.
Publicado: (2022)

An integrated understanding of the evolutionary and structural features of the SARS-CoV-2 spike receptor binding domain (RBD)
por: Sanyal, Dwipanjan, et al.
Publicado: (2022)

Human antibody recognition and neutralization mode on the NTD and RBD domains of SARS-CoV-2 spike protein
por: Otsubo, Ryota, et al.
Publicado: (2022)

Dynamic Assay for Profiling Anti-SARS-CoV-2 Antibodies and Their ACE2/Spike RBD Neutralization Capacity
por: Phelan, Thomas, et al.
Publicado: (2021)

Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assays
por: Rikhtegaran Tehrani, Zahra, et al.
Publicado: (2020)

The HPV Serology Laboratory leads an initiative to standardize and harmonize human papillomavirus serology assays
por: Park, Isabel, et al.
Publicado: (2023)

Computer aided prediction and identification of potential epitopes in the receptor binding domain (RBD) of spike (S) glycoprotein of MERS-CoV
por: ali, Mohammad Tuhin, et al.
Publicado: (2014)

Multivalent Display of SARS-CoV-2 Spike (RBD Domain) of COVID-19 to Nanomaterial, Protein Ferritin Nanocages
por: Kalathiya, Umesh, et al.
Publicado: (2021)

Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays
por: Passariello, Margherita, et al.
Publicado: (2023)

Identification of SARS-CoV-2-against aptamer with high neutralization activity by blocking the RBD domain of spike protein 1
por: Yang, Ge, et al.
Publicado: (2021)

Platelet Reactivity and Inflammatory Phenotype Induced by Full-Length Spike SARS-CoV-2 Protein and Its RBD Domain
por: Cano-Mendez, Alan, et al.
Publicado: (2022)

Specificity and Performance of Nucleocapsid and Spike-based SARS-CoV-2 Serologic Assays
por: Tehrani, Zahra Rikhtegaran, et al.
Publicado: (2020)

Immunoglobulin yolk targeting spike 1, receptor binding domain of spike glycoprotein and nucleocapsid of SARS-CoV-2 blocking RBD-ACE2 binding interaction
por: Eka Saputri, Meliana, et al.
Publicado: (2022)

Towards Quantitative and Standardized Serological and Neutralization Assays for COVID-19
por: Tian, Linhua, et al.
Publicado: (2021)

A newly identified linear epitope on non-RBD region of SARS-CoV-2 spike protein improves the serological detection rate of COVID-19 patients
por: Zhang, Yunwen, et al.
Publicado: (2021)

Jacareubin inhibits TLR4-induced lung inflammatory response caused by the RBD domain of SARS-CoV-2 Spike protein
por: Segura-Villalobos, Deisy, et al.
Publicado: (2022)

Large-Scale Purification and Characterization of Recombinant Receptor-Binding Domain (RBD) of SARS-CoV-2 Spike Protein Expressed in Yeast
por: Nagar, Gaurav, et al.
Publicado: (2023)

Multiepitope Proteins for the Differential Detection of IgG Antibodies against RBD of the Spike Protein and Non-RBD Regions of SARS-CoV-2
por: Gomes, Larissa R., et al.
Publicado: (2021)

The WHO International Standard for COVID-19 serological tests: towards harmonization of anti-spike assays
por: Infantino, Maria, et al.
Publicado: (2021)

Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States
por: Kalish, Heather, et al.
Publicado: (2021)

Mapping a Pandemic: SARS-CoV-2 Seropositivity in the United States
por: Kalish, Heather, et al.
Publicado: (2021)

Pre-pandemic SARS-CoV-2 serological reactivity in rural malaria-experienced Cambodians
por: Manning, Jessica, et al.
Publicado: (2021)

Development and Evaluation of a Set of Spike and Receptor Binding Domain-Based Enzyme-Linked Immunosorbent Assays for SARS-CoV-2 Serological Testing
por: Camacho-Sandoval, Rosa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pom7ha9iqji3l9lhpbtmm1045t